Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Berlin - Delayed Quote EUR

Open Orphan PLC (CRO.BE)

Compare
0.2120
0.0000
(0.00%)
As of 7:27:05 PM GMT+1. Market Open.
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
56,043
56,043
48,477
36,864
20,602
Cost of Revenue
24,170
--
--
963
727
Gross Profit
31,873
--
--
35,901
19,875
Operating Expense
45,722
45,722
42,335
36,568
28,485
Operating Income
10,321
10,321
6,142
296
-8,610
Net Non Operating Interest Income Expense
1,005
1,005
4
-215
-374
Pretax Income
11,147
11,147
-365
277
-10,980
Tax Provision
-4,968
-4,968
411
351
-189
Net Income Common Stockholders
16,115
16,115
-776
-74
-10,791
Diluted NI Available to Com Stockholders
16,115
16,115
-776
-74
-10,791
Basic EPS
0.02
0.02
-0.00
-0.00
-0.02
Diluted EPS
0.02
0.02
-0.00
-0.00
-0.02
Basic Average Shares
677,444.1330
677,444.1330
670,943.9180
670,187.3130
599,920.2070
Diluted Average Shares
685,847.3150
685,847.3150
688,710.3740
670,187.3130
599,920.2070
Total Operating Income as Reported
10,102
10,102
6,023
590
-10,259
Rent Expense Supplemental
--
--
--
1,399
1,331
Total Expenses
45,722
45,722
42,335
36,568
29,212
Net Income from Continuing & Discontinued Operation
16,115
16,115
-776
-74
-10,791
Normalized Income
16,292.3900
16,292.3900
4,955.5600
-290.2700
-8,934.5156
Interest Income
1,181
1,181
136
12
--
Interest Expense
155
155
133
227
374
Net Interest Income
1,005
1,005
4
-215
-374
EBIT
11,302
11,302
-232
504
-10,606
EBITDA
14,018
14,018
2,698
3,069
-8,554
Reconciled Cost of Revenue
24,170
--
--
963
727
Reconciled Depreciation
2,716
2,716
2,930
2,565
2,052
Net Income from Continuing Operation Net Minority Interest
16,115
16,115
-776
-74
-10,791
Total Unusual Items Excluding Goodwill
-219
-219
-7,076
267
-1,889
Total Unusual Items
-219
-219
-7,076
267
-1,889
Normalized EBITDA
14,237
14,237
9,774
2,802
-6,665
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
-41.6100
-41.6100
-1,344.4400
50.7300
-32.5156
12/31/2020 - 2/2/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2X10.F ABIVAX Société Anonyme
6.75
+2.27%
 
PHPN.F Galectin Therapeutics Inc.
1.4300
0.00%
 
6XY.F HBM Holdings Limited
0.6200
-3.12%
 
HPHA.F Heidelberg Pharma AG
2.3100
0.00%
 
J90.F NurExone Biologic Inc.
0.3920
-0.51%
 
ALTME.PA TME Pharma N.V.
0.0747
+0.40%
 
SEOVF Sernova Biotherapeutics Inc
0.1414
+1.00%
 
SVA.TO Sernova Biotherapeutics Inc
0.2050
+5.13%
 
ALLK Allakos Inc.
0.2911
-0.75%
 
ACIU AC Immune SA
2.6500
-1.48%